Mitsubishi's Medicago readies for the second wave

Alongside rollout of the first generation of Covid-19 vaccines the next wave of shots is being pushed through the clinic. These will help supply global markets and meet demand for the boosters thought likely to be required in the coming years, and it is here that Mitsubishi Tanabe's Canadian subsidiary Medicago hopes to step in.